Inventor · disambiguated record
Brian T. Hopkins
Also filed as: HOPKINS BRIAN · HOPKINS BRIAN T
33 granted patents·15 pending applications·163 citations·filing 2005–2024
97Inventor score
Files withBIOGEN MA INC25CASTRO ALFREDO C5SUNESIS PHARMACEUTICALS INC4VIRACTA THERAPEUTICS INC4BIOGEN IDEC INC3
Top patents by PatentIndex Score
48 records- 0193US11427577B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2021·Granted Aug 30, 2022·2 cites·9 claims
- 0292US10961237B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2019·Granted Mar 30, 2021·4 cites·6 claims
- 0392US9790229B2Bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Oct 17, 2017·11 cites·21 claims
- 0491US10081619B2Biaryl inhibitors of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2017·Granted Sep 25, 2018·7 cites·4 claims
- 0591US9944622B2Pyrimidinyl tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Granted Apr 17, 2018·8 cites·16 claims
- 0691US9809577B2Biaryl inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2014·Granted Nov 7, 2017·12 cites·2 claims
- 0791US9353087B2Inhibitors of Bruton's tyrosine kinaseBIOGEN IDEC INC·Filed 2013·Granted May 31, 2016·8 cites·19 claims
- 0891US8785440B2Bruton's tyrosine kinase inhibitorsBUI MINNA·Filed 2010·Granted Jul 22, 2014·20 cites·20 claims
- 0990US10759783B2Biaryl inhibitors of Bruton'S tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Sep 1, 2020·3 cites·11 claims
- 1090US10227341B2Inhibiting agents for bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Mar 12, 2019·8 cites·26 claims
- 1189US10189829B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Jan 29, 2019·6 cites·8 claims
- 1289US9394277B2Pyrimidinyl tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2013·Granted Jul 19, 2016·11 cites·26 claims
- 1389US9249146B2Bruton'S tyrosine kinase inhibitorsBIOGEN IDEC INC·Filed 2014·Granted Feb 2, 2016·9 cites·25 claims
- 1486US7842815B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2006·Granted Nov 30, 2010·5 cites·3 claims
- 1585US7851637B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY PHARMACEUTICALS INC·Filed 2005·Granted Dec 14, 2010·13 cites·17 claims
- 1684US10618887B2Pyrimidinyl tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Granted Apr 14, 2020·3 cites·17 claims
- 1784US9029359B2Heteroaryl Btk inhibitorsBUI MINNA·Filed 2010·Granted May 12, 2015·12 cites·18 claims
- 1884US2024246988A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1983US9273028B2Heterocyclic tyrosine kinase inhibitorsHOPKINS BRIAN T·Filed 2011·Granted Mar 1, 2016·6 cites·8 claims
- 2083US2024417389A1Pyrimidinyl tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2182US11858926B2Inhibiting agents for bruton's tyrosine kinaseBIOGEN MA INC·Filed 2022·Granted Jan 2, 2024·0 cites·5 claims
- 2282US10577374B2Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2017·Granted Mar 3, 2020·2 cites·18 claims
- 2381US9198420B2Rodenticidal norbormide analoguesLANDCARE RES NEW ZEALAND LTD·Filed 2013·Granted Dec 1, 2015·9 cites·20 claims
- 2480US12391697B2Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Aug 19, 2025·1 cites·20 claims
- 2578US2023046457A1Bruton's tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2677US2023174511A1Pyrimidinyl tyrosine kinase inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2773US10899753B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2019·Granted Jan 26, 2021·1 cites·20 claims
- 2873US8461191B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2010·Granted Jun 11, 2013·1 cites·38 claims
- 2970US2020399283A1Bruton's tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3068US11572356B2Biaryl inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Feb 7, 2023·0 cites·17 claims
- 3168US2021017155A1Pyrimidinyl tyrosine kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3266US10280169B2Biaryl bruton's tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2014·Granted May 7, 2019·1 cites·16 claims
- 3363US10189817B2Inhibitors of Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2018·Granted Jan 29, 2019·0 cites·6 claims
- 3459US7928244B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersINFINITY DISCOVERY INC·Filed 2007·Granted Apr 19, 2011·0 cites·37 claims
- 3557US2025034150A1Btk inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 3657US2025090524A1Btk inhibitorsBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 3756US8178690B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2011·Granted May 15, 2012·0 cites·15 claims
- 3856US2024287076A1Compounds for targeting degradation of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 3954US8609706B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2012·Granted Dec 17, 2013·0 cites·14 claims
- 4054US7745464B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2006·Granted Jun 29, 2010·0 cites·18 claims
- 4154US2017114039A1Inhibitors of bruton's tyrosine kinaseBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 4252US2024083900A1Pyrazolo[1,5-a]pyrazine derivatives as btk inhibitorsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 4352US2024327380A1Btk inhibitorsBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 4451US2024216330A1Combination treatment methods of multiple sclerosisBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 4550US2017027956A1Heterocyclic tyrosine kinase inhibitorsBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 4649US12240838B2Inhibiting agents for Bruton's tyrosine kinaseBIOGEN MA INC·Filed 2020·Granted Mar 4, 2025·0 cites·21 claims
- 4744US8304428B2Compounds and methods for inhibiting the interaction of BCL proteins with binding partnersCASTRO ALFREDO C·Filed 2010·Granted Nov 6, 2012·0 cites·41 claims
- 4844US2022089592A1Imidazo[1,2-a]pyridinyl derivatives as irak4 inhibitorsBIOGEN MA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian T. Hopkins files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →